Technical Analysis for QDEL - Quidel Corporation

Grade Last Price % Change Price Change
grade B 175.73 0.42% 0.73
QDEL closed up 4.65 percent on Friday, May 29, 2020, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical QDEL trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.42%
Narrow Range Bar Range Contraction 0.42%
NR7 Range Contraction 0.42%
Multiple of Ten Bullish Other 0.42%
Wide Bands Range Expansion 0.42%
20 DMA Resistance Bearish 5.09%
New Uptrend Bullish 5.09%
Multiple of Ten Bearish Other 5.09%
Multiple of Ten Bullish Other 5.09%
Wide Bands Range Expansion 5.09%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women's health, and gastrointestinal diseases. The company's products for infectious diseases include QuickVue influenza test to detect viral antigens of influenza type A and B; QuickVue Strep A tests to detect Group A Streptococcal antigen from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture; QuickVue RSV test, a rapid immunoassay for respiratory syncitial virus; and cell culture and DFA detection solutions to detect seven viral respiratory pathogens. It also offers cell-based products in various formats, including tubes, shell vials, and multi-well plates to culture and test for human viruses; ELVIS HSV system for the isolation and detection of herpes simplex virus (HSV) types 1 and 2; and a multiplex cell culture solution to isolate HSV, varicella zoster virus, and cytomegalovirus, as well as provides various analyzers and molecular assays. The company's products for women's health consist of QuickVue and RapidVue pregnancy tests to detect human chorionic gonoadotropin in serum or urine for the early detection of pregnancy; Thyretain for the diagnosis of graves, an autoimmune disease; QuickVue Chlamydia test to detect chlamydia trachomatis from endocervical swab and cytology brush specimens; and clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation, including metabolic bone markers to monitor the effectiveness of therapy in pharmaceutical and related research. In addition, it provides a fecal immunochemical test to detect the presence of blood in stool specimens; indirect fluorescent antibody products; and Helicobacter pylori tests, as well as develops diagnostic and research products in the fields of oncology, bone health, and autoimmune diseases. The company was founded in 1979 and is headquartered in San Diego, California.
Medicine Medical Specialties Infectious Diseases Autoimmune Diseases Influenza Infectious Causes Of Cancer Autoimmune Disease Gastrointestinal Diseases Osteoporosis Herpes Simplex Virus Sexually Transmitted Diseases And Infections Detection Solutions

Is QDEL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 210.81
52 Week Low 52.49
Average Volume 985,957
200-Day Moving Average 84.73
50-Day Moving Average 131.04
20-Day Moving Average 169.86
10-Day Moving Average 176.76
Average True Range 13.31
ADX 36.49
+DI 32.14
-DI 26.14
Chandelier Exit (Long, 3 ATRs ) 170.87
Chandelier Exit (Short, 3 ATRs ) 172.78
Upper Bollinger Band 209.23
Lower Bollinger Band 130.49
Percent B (%b) 0.57
BandWidth 46.36
MACD Line 11.48
MACD Signal Line 15.47
MACD Histogram -3.9866
Fundamentals Value
Market Cap 5.83 Billion
Num Shares 33.3 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 6.50
Price-to-Book 6.54
PEG Ratio 7.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 183.87
Resistance 3 (R3) 183.02 179.21 182.39
Resistance 2 (R2) 179.21 176.96 179.64 181.89
Resistance 1 (R1) 177.11 175.56 178.16 177.96 181.40
Pivot Point 173.30 173.30 173.83 173.73 173.30
Support 1 (S1) 171.20 171.05 172.25 172.05 168.60
Support 2 (S2) 167.39 169.65 167.82 168.11
Support 3 (S3) 165.29 167.39 167.61
Support 4 (S4) 166.14